Oncology
FDA/CDC
Atezolizumab combination regimen approved for advanced non-squamous NSCLC
The FDA approved checkpoint inhibitor atezolizumab for the treatment of metastatic non-squamous NSCLC with no EGFR or ALK genomic tumor...
Conference Coverage
2018: A banner year for hematology drug approvals
SAN DIEGO – There have been 32 new hematology drug approvals and the year isn’t over yet.
Reports From the Field
Early intervention initiative cut oncology patient hospitalizations
An after-hours phone triage system, proactive chemotherapy follow-up calls, and a Saturday-Sunday urgent care clinic resulted in early...
Reports From the Field
Screening for Lynch Syndrome Among Patients with Colorectal Cancer: Experiences from a Multihospital Health System
Video
Gut bacteria influence HCT outcomes
SAN DIEGO – Gut microbiome diversity predicts overall survival after hematopoietic cell transplant.
FDA/CDC
Heart disease remains the leading cause of death in U.S.
Stroke, diabetes, and Alzheimer’s deaths are up in 2017.
News
New data further support curability of myeloma
A study has found that a sizable share of transplant-eligible patients can expect to live as long as similar people in the general population.
News
ASH releases new VTE guidelines
A panel of the American Society of Hematology released more than 150 recommendations for dealing with venous thromboembolism.
Article
Patterns of malignancies in patients with HIV-AIDS: a single institution observational study
Conference Coverage
Use of smartphone app improves pain outcomes
SAN DIEGO – A smartphone app with artificial intelligence elements improved pain outcomes and reduced hospital...